Clinical Trials Directory

Trials / Completed

CompletedNCT03940456

Prognostic Factors of Importance on Who Develops Chronic Low Back Pain

Prognostic Factors of Importance on Who Develops Chronic Low Back Pain: A Protocol Update for an Inception Cohort With Focus on Prognostic Factors With 54 Years of Follow up

Status
Completed
Phase
Study type
Observational
Enrollment
607 (actual)
Sponsor
Frederiksberg University Hospital · Academic / Other
Sex
All
Age
67 Years – 69 Years
Healthy volunteers
Accepted

Summary

The incidence of low back pain (LBP) is increasing and prognostic factors for developing LBP are unclear. Based on questionnaires, different prognostic factors are being explored over time.

Detailed description

Despite massive efforts of trying to find predictors and prevention for LBP, it remains to be clarified, why some individuals develop severely disabling low back pain while others never experience noteworthy back pain. There is no evidence that numbers of chronically affected individuals have diminished; rather, the incidence of LBP has increased continuously over the last 20 years which is also reflected in rising numbers of lumbar surgical treatments. The prevalence and burden increase with age and prevention of LBP in an aging population seems more urgent than ever. As LBP is undoubtedly a multifaceted disorder that tends to fluctuate throughout life, there is a need for longitudinal research, exploring the effect of both life style and psychosocial factors on the development of chronic low back pain. The aim of this study is to identify whether a history of low back pain during adolescence represents an increased risk of experiencing low back pain later in life.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireQuestionnaire mainly focusing on low back pain, pain related disorders, psychosocial factors and the use of alternative treatments for pain

Timeline

Start date
2019-05-08
Primary completion
2019-09-24
Completion
2019-09-24
First posted
2019-05-07
Last updated
2025-02-27

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03940456. Inclusion in this directory is not an endorsement.